Compagnie Lombard Odier SCmA reduced its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 6.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 153,413 shares of the financial services provider’s stock after selling 11,278 shares during the quarter. Compagnie Lombard Odier SCmA’s holdings in MetLife were worth $12,110,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Vermillion & White Wealth Management Group LLC increased its stake in MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after buying an additional 316 shares during the last quarter. Foster Dykema Cabot & Partners LLC bought a new position in shares of MetLife in the 3rd quarter valued at about $32,000. JPL Wealth Management LLC bought a new position in shares of MetLife in the 3rd quarter valued at about $33,000. Salomon & Ludwin LLC increased its position in shares of MetLife by 95.4% in the third quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 206 shares during the last quarter. Finally, True Wealth Design LLC raised its holdings in MetLife by 564.1% during the third quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 361 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages recently commented on MET. Morgan Stanley decreased their price target on MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Evercore set a $95.00 price objective on MetLife in a research note on Tuesday, February 10th. Weiss Ratings downgraded MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, March 9th. TD Cowen decreased their target price on shares of MetLife from $91.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, March 11th. Finally, Wells Fargo & Company lowered their target price on shares of MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $93.42.
MetLife Trading Up 0.7%
MetLife stock opened at $71.22 on Thursday. The stock has a 50-day simple moving average of $73.86 and a 200 day simple moving average of $77.33. The stock has a market capitalization of $46.44 billion, a P/E ratio of 15.15, a PEG ratio of 0.64 and a beta of 0.74. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $83.85.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The firm had revenue of $52.44 billion for the quarter, compared to analyst estimates of $31.43 billion. During the same quarter in the prior year, the company earned $2.08 earnings per share. The business’s revenue for the quarter was up 27.6% compared to the same quarter last year. Analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd were paid a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date was Tuesday, February 3rd. MetLife’s dividend payout ratio is 48.30%.
MetLife Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Featured Articles
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
